Immunodiagnostic Systems Holdings plc provides revenue guidance for the year ended March 31, 2015 and March 31, 2016. For the year ended March 31, 2015 revenues are expected to be £45 million in line with the guidance reconfirmed in April 2015.


The board expects that for the current financial year to 31 March 2016 revenues will be in the range of £39-£42 million.